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The early phases of drug discovery use in silico models
to rationalize structure activity relationships, and to pre-
dict the activity of novel compounds. However, the per-
formance of these models is not always acceptable and
the reliability of external predictions - both to novel
compounds and to related protein targets - is often lim-
ited. Proteochemometric modeling [1] adds a target
description, based on physicochemical properties of the
binding site, to these models.
Our proteochemometric models [2] are based on Sci-
tegic circular fingerprints on the compound side and on
a customized protein fingerprint on the target side. This
protein fingerprint is based on a selection of physico-
chemical descriptors obtained from the AAindex data-
base. Through PCA we selected a number of
physicochemical properties which are hashed in a fin-
gerprint using the Scitegic hashing algorithm. We com-
pared this fingerprint to a number of protein descriptors
previously published, including the Z-scales, the FAS-
GAI and the BLOSUM descriptors. Our fingerprint per-
forms superior to all of these. In addition, we show that
proteochemometric models improve external prediction
capabilities. In the case of classification this leads to
models with a higher specificity when compared to con-
ventional QSAR. In the case of regression our models
show an average lower RMSE of 0.12 log units when
b a s e do nap I C 5 0o u t p u tv a r i a b l ec o m p a r e dt oc o n v e n -
tional QSAR modeling the same data-set. Furthermore,
our models enable target extrapolation. As a result we
can predict the activity of known and new compounds
on new targets while retaining the same model quality
as when performing external validation without target
extrapolation.
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